Aimei Health Technology Co. Ltd. Secures $150,000 Promissory Note Extension for Business Combination with United Hydrogen
Aimei Health Technology Co. Ltd. has announced an amendment to its existing financial arrangements by securing an unsecured promissory note amounting to $150,000. The agreement, dated September 5, 2025, involves Aimei Health Ltd and United Hydrogen Group Inc., both exempted companies incorporated in the Cayman Islands, as equal contributors to the loan. This financing allows Aimei Health Technology to extend the deadline for completing its initial business combination to October 6, 2025. The promissory note, which bears no interest, is set to mature upon the successful consummation of a business combination with United Hydrogen. Additionally, the lenders have the option to convert the note into private units of Aimei Health Technology, offering flexibility in the agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-012726), on September 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.